Diabetes Care, Vol 23, Issue 1 9-14, Copyright © 2000 by American Diabetes Association

ARTICLES

Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial

V Vuksan, JL Sievenpiper, R Owen, JA Swilley, P Spadafora, DJ Jenkins, E Vidgen, F Brighenti, RG Josse, LA Leiter, Z Xu and R Novokmet
Department of Nutritional Sciences, St. Michael's Hospital, University of Toronto, Canada. v.vuksan@utoronto.ca

OBJECTIVE: Dietary fiber has recently received recognition for reducing the risk of developing diabetes and heart disease. The implication is that it may have therapeutic benefit in prediabetic metabolic conditions. To test this hypothesis, we investigated the effect of supplementing a high-carbohydrate diet with fiber from Konjac-mannan (KJM) on metabolic control in subjects with the insulin resistance syndrome. RESEARCH DESIGN AND METHODS: We screened 278 free-living subjects between the ages of 45 and 65 years from the Canadian-Maltese Diabetes Study. A total of 11 (age 55+/-4 years, BMI 28+/-1.5 kg/m2) were recruited who satisfied the inclusion criteria: impaired glucose tolerance, reduced HDL cholesterol, elevated serum triglycerides, and moderate hypertension. After an 8-week baseline, they were randomly assigned to take either KJM fiber-enriched test biscuits (0.5 g of glucomannan per 100 kcal of dietary intake or 8-13 g/day) or wheat bran fiber (WB) control biscuits for two 3-week treatment periods separated by a 2-week washout. The diets were isoenergetic, metabolically controlled, and conformed to National Cholesterol Education Program Step 2 guidelines. Serum lipids, glycemic control, and blood pressure were the outcome measures. RESULTS: Decreases in serum cholesterol (total, 12.4+/-3.1%, P<0.004; LDL, 22+/-3.9%, P<0.002; total/HDL ratio, 15.2+/-3.4%, P<0.003; and LDL/HDL ratio, 22.2+/-4.1%, P< 0.002), apolipoprotein (apo) B (15.1+/-4.3%, P<0.0004), apo B/A-1 ratio (13.1+/-3.4%, P< 0.0003), and serum fructosamine (5.2+/-1.4%, P<0.002) were observed during KJM treatment compared with WB-control. Fasting blood glucose, insulin, triglycerides, HDL cholesterol, and body weight remained unchanged. CONCLUSIONS: A diet rich in high-viscosity KJM improves glycemic control and lipid profile, suggesting a therapeutic potential in the treatment of the insulin resistance syndrome.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Sood, W. L Baker, and C. I Coleman Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1167 - 1175. [Abstract] [Full Text] [PDF]

				A. D. Azezli, T. Bayraktaroglu, and Y. Orhan The Use of Konjac Glucomannan to Lower Serum Thyroid Hormones in Hyperthyroidism J. Am. Coll. Nutr., December 1, 2007; 26(6): 663 - 668. [Abstract] [Full Text] [PDF]

				M. A Pereira Weighing in on glycemic index and body weight. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 677 - 679. [Full Text] [PDF]

				A. M. Flammang, D. M. Kendall, C. J. Baumgartner, T. D. Slagle, and Y. S. Choe Effect of a viscous fiber bar on postprandial glycemia in subjects with type 2 diabetes. J. Am. Coll. Nutr., October 1, 2006; 25(5): 409 - 414. [Abstract] [Full Text] [PDF]

				N. M. McKeown, J. B. Meigs, S. Liu, E. Saltzman, P. W.F. Wilson, and P. F. Jacques Carbohydrate Nutrition, Insulin Resistance, and the Prevalence of the Metabolic Syndrome in the Framingham Offspring Cohort Diabetes Care, February 1, 2004; 27(2): 538 - 546. [Abstract] [Full Text] [PDF]

				G. F Keogh, G. J. Cooper, T. B Mulvey, B. H McArdle, G. D Coles, J. A Monro, and S. D Poppitt Randomized controlled crossover study of the effect of a highly {beta}-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men Am. J. Clinical Nutrition, October 1, 2003; 78(4): 711 - 718. [Abstract] [Full Text] [PDF]

				J. Busserolles, E. Gueux, E. Rock, C. Demigne, A. Mazur, and Y. Rayssiguier Oligofructose Protects against the Hypertriglyceridemic and Pro-oxidative Effects of a High Fructose Diet in Rats J. Nutr., June 1, 2003; 133(6): 1903 - 1908. [Abstract] [Full Text] [PDF]

				G. Y. Yeh, D. M. Eisenberg, T. J. Kaptchuk, and R. S. Phillips Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes Diabetes Care, April 1, 2003; 26(4): 1277 - 1294. [Abstract] [Full Text] [PDF]

				H.-L. Chen, W. H.-H. Sheu, T.-S. Tai, Y.-P. Liaw, and Y.-C. Chen Konjac Supplement Alleviated Hypercholesterolemia and Hyperglycemia in Type 2 Diabetic Subjects--A Randomized Double-Blind Trial J. Am. Coll. Nutr., February 1, 2003; 22(1): 36 - 42. [Abstract] [Full Text] [PDF]

				References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text]

				P. J. Jones Clinical nutrition: 7. Functional foods -- more than just nutrition Can. Med. Assoc. J., June 1, 2002; 166(12): 1555 - 1563. [Full Text] [PDF]

				V. Vuksan, J. L. Sievenpiper, Z. Xu, E. Y. Y. Wong, A. L. Jenkins, U. Beljan-Zdravkovic, L. A. Leiter, R. G. Josse, and M. P. Stavro Konjac-Mannan and American Ginsing: Emerging Alternative Therapies for Type 2 Diabetes Mellitus J. Am. Coll. Nutr., October 1, 2001; 20(90005): 370S - 380. [Abstract] [Full Text]

				H. Fujita, T. Yamagami, and K. Ohshima Long-Term Ingestion of a Fermented Soybean-Derived Touchi-Extract with {alpha}-Glucosidase Inhibitory Activity Is Safe and Effective in Humans with Borderline and Mild Type-2 Diabetes J. Nutr., August 1, 2001; 131(8): 2105 - 2108. [Abstract] [Full Text] [PDF]